Literature DB >> 28457647

British Gynaecological Cancer Society (BGCS) epithelial ovarian/fallopian tube/primary peritoneal cancer guidelines: recommendations for practice.

Christina Fotopoulou1, Marcia Hall2, Derek Cruickshank3, Hani Gabra4, Raji Ganesan2, Cathy Hughes5, Sean Kehoe6, Jonathan Ledermann7, Jo Morrison8, Raj Naik9, Phil Rolland10, Sudha Sundar11.   

Abstract

Entities:  

Year:  2017        PMID： 28457647     DOI： 10.1016/j.ejogrb.2017.04.016

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN： 0301-2115            Impact factor:   2.435


× No keyword cloud information.
  12 in total

1.  Enhancing delivery of small molecule and cell-based therapies for ovarian cancer using advanced delivery strategies.

Authors:  Joanne O'Dwyer; Roisin E O'Cearbhaill; Robert Wylie; Saoirse O'Mahony; Michael O'Dwyer; Garry P Duffy; Eimear B Dolan
Journal:  Adv Ther (Weinh)       Date:  2020-08-16

Review 2.  Considerations for multimodal prehabilitation in women with gynaecological cancers: a scoping review using realist principles.

Authors:  Rhia Kaur Saggu; Phillip Barlow; John Butler; Sadaf Ghaem-Maghami; Cathy Hughes; Pernilla Lagergren; Alison H McGregor; Clare Shaw; Mary Wells
Journal:  BMC Womens Health       Date:  2022-07-19       Impact factor: 2.742

3.  Fertility Preserving Surgery Outcomes for Ovarian Malignancy: Data from a Tertiary Cancer Centre in Central London.

Authors:  Jonathan Gaughran; Hannah Rosen O'Sullivan; Tom Lyne; Ahmed Abdelbar; Mostafa Abdalla; Ahmad Sayasneh
Journal:  J Clin Med       Date:  2022-06-03       Impact factor: 4.964

4.  Conditional Relative Survival of Ovarian Cancer: A Korean National Cancer Registry Study.

Authors:  Dong Wook Shin; Jaeman Bae; Johyun Ha; Kyu-Won Jung
Journal:  Front Oncol       Date:  2021-04-28       Impact factor: 6.244

5.  Clinical Usefulness of Cancer Antigen (CA) 125, Human Epididymis 4, and CA72-4 Levels and Risk of Ovarian Malignancy Algorithm Values for Diagnosing Ovarian Tumors in Korean Patients With and Without Endometriosis.

Authors:  Kyung Hwa Shin; Hyung Hoi Kim; Byung Su Kwon; Dong Soo Suh; Jong Kil Joo; Ki Hyung Kim
Journal:  Ann Lab Med       Date:  2020-01       Impact factor: 3.464

6.  Maximal-Effort Cytoreductive Surgery for Ovarian Cancer Patients with a High Tumor Burden: Variations in Practice and Impact on Outcome.

Authors:  Marcia Hall; Konstantinos Savvatis; Katherine Nixon; Maria Kyrgiou; Kuhan Hariharan; Malcolm Padwick; Owen Owens; Paula Cunnea; Jeremy Campbell; Alan Farthing; Richard Stumpfle; Ignacio Vazquez; Neale Watson; Jonathan Krell; Hani Gabra; Gordon Rustin; Christina Fotopoulou
Journal:  Ann Surg Oncol       Date:  2019-06-26       Impact factor: 5.344

7.  Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study.

Authors:  Amy Hawarden; Bryn Russell; Mary Ellen Gee; Fatima Kayali; Andrew Clamp; Emma Jayne Crosbie; Richard John Edmondson
Journal:  BMC Cancer       Date:  2021-04-08       Impact factor: 4.430

8.  Peritoneal Cancer Mimicking Sclerosing Mesenteritis: A Case Report.

Authors:  Naoto Mouri; Ryuichi Ohta; Chiaki Sano
Journal:  Cureus       Date:  2022-01-04

9.  Explainable Artificial Intelligence for Prediction of Complete Surgical Cytoreduction in Advanced-Stage Epithelial Ovarian Cancer.

Authors:  Alexandros Laios; Evangelos Kalampokis; Racheal Johnson; Amudha Thangavelu; Constantine Tarabanis; David Nugent; Diederick De Jong
Journal:  J Pers Med       Date:  2022-04-10

Review 10.  Integrative radiogenomics for virtual biopsy and treatment monitoring in ovarian cancer.

Authors:  Paula Martin-Gonzalez; Mireia Crispin-Ortuzar; Leonardo Rundo; Maria Delgado-Ortet; Marika Reinius; Lucian Beer; Ramona Woitek; Stephan Ursprung; Helen Addley; James D Brenton; Florian Markowetz; Evis Sala
Journal:  Insights Imaging       Date:  2020-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.